Sarepta Therapeutics Ownership | Who Owns Sarepta Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Sarepta Therapeutics Ownership Summary

Sarepta Therapeutics is owned by 93.90% institutional investors, 4.37% insiders, and 1.73% retail investors. Blackrock is the largest institutional shareholder, holding 10.98% of SRPT shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.14% of its assets in Sarepta Therapeutics shares.

SRPT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Sarepta Therapeutics	93.90%	4.37%	1.73%
Sector	Healthcare Stocks	46.98%	7.90%	45.12%
Industry	Biotech Stocks	44.85%	7.67%	47.48%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	10.32M	10.98%	$1.63B
Vanguard group	9.04M	9.61%	$1.43B
Capital investors	4.32M	4.60%	$682.69M
State street	4.14M	4.41%	$654.40M
Janus henderson group	3.82M	4.06%	$602.74M
Avoro capital advisors	3.00M	3.19%	$474.00M
Morgan stanley	2.62M	2.79%	$414.49M
Bank of new york mellon	2.13M	2.27%	$336.64M
Wellington management group llp	2.06M	2.19%	$325.72M
T. rowe price investment management	1.96M	2.08%	$309.46M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Casdin capital	1.07M	12.95%	$169.61M
Ally bridge group (ny)	73.50K	6.92%	$11.61M
Ecor1 capital	1.41M	6.80%	$222.36M
Avoro capital advisors	3.00M	6.31%	$474.00M
Finepoint capital lp	132.84K	5.96%	$20.99M
Paradigm biocapital advisors lp	947.57K	5.73%	$149.72M
Boxer capital	650.00K	5.41%	$102.70M
Altium capital management lp	81.90K	5.28%	$12.94M
Exome asset management	32.90K	4.63%	$5.20M
Palo alto investors lp	201.68K	3.69%	$31.87M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	10.32M	0.04%	4.36M
State street	4.14M	0.03%	2.02M
Morgan stanley	2.62M	0.03%	1.73M
Norges bank	924.43K	0.02%	924.43K
Jane street group	869.13K	0.03%	591.02K

Top Sellers

Holder	Shares	% Assets	Change
Avoro capital advisors	3.00M	6.31%	-1.34M
Wellington management group llp	2.06M	0.06%	-1.18M
Janus henderson group	3.82M	0.32%	-1.08M
Perceptive advisors	-	-	-525.68K
Ecor1 capital	1.41M	6.80%	-512.51K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	924.43K	0.02%	924.43K	$146.06M
Farallon capital management	133.30K	0.10%	133.30K	$21.06M
Balyasny asset management	125.00K	0.03%	125.00K	$19.75M
Cormorant asset management, lp	125.00K	1.14%	125.00K	$19.75M
Corebridge financial	120.64K	0.10%	120.64K	$19.06M

Sold Out

Holder	Change
Harbor investment advisory	-1.00
Financial gravity asset management	-1.00
Financial synergies wealth advisors	-3.00
Financial management professionals	-4.00
Geneos wealth management	-4.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	528	18.39%	88,255,346	8.04%	93	1.24%	293	35.02%	132	4.76%
Mar 31, 2024	446	1.59%	81,685,557	0.50%	86	1.12%	217	7.43%	126	-11.89%
Dec 31, 2023	439	-1.79%	81,281,399	-0.52%	87	1.04%	202	-1.94%	143	12.60%
Sep 30, 2023	447	1.13%	81,706,199	0.21%	91	1.09%	206	-0.48%	127	-5.93%
Jun 30, 2023	442	-4.74%	81,534,101	1.32%	91	1.10%	207	-5.05%	135	-2.17%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Mid-Cap ETF	3.00M	3.14%	1.63K
Vanguard Total Stock Mkt Idx Inv	2.85M	2.99%	2.16K
Vanguard Small Cap Index	2.27M	2.38%	-3.61K
VA CollegeAmerica Amcap 529A	2.10M	2.20%	902.69K
Capital Group AMCAP Composite	2.10M	2.20%	902.69K
Vanguard Health Care Inv	1.66M	1.74%	390.96K
Capital Group Growth Fnd of Amer Comp	1.65M	1.73%	194.73K
American Funds Growth Fund of Amer A	1.65M	1.73%	194.73K
SPDR® S&P Biotech ETF	1.50M	1.57%	16.57K
Vanguard Institutional Extnd Mkt Idx Tr	1.43M	1.50%	-18.88K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 30, 2024	Estepan Ian Michael	Chief Financial Officer	Sell	$822.10K
Aug 16, 2024	Chambers Michael Andrew	-	Buy	$2.45M
Aug 16, 2024	Chambers Michael Andrew	-	Buy	$760.56K
Aug 16, 2024	Chambers Michael Andrew	-	Buy	$1.74M
Jun 25, 2024	Brown Ryan Edward	EVP, General Counsel	Sell	$1.21M

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q3	3	1
2024 Q2	-	14
2024 Q1	-	9
2023 Q4	6	-

SRPT Ownership FAQ

Who Owns Sarepta Therapeutics?

Sarepta Therapeutics shareholders are primarily institutional investors at 93.90%, followed by 4.37% insiders and 1.73% retail investors. The average institutional ownership in Sarepta Therapeutics's industry, Biotech Stocks , is 44.85%, which Sarepta Therapeutics exceeds.

Who owns the most shares of Sarepta Therapeutics?

Sarepta Therapeutics’s largest shareholders are Blackrock (10.32M shares, 10.98%), Vanguard group (9.04M shares, 9.61%), and Capital investors (4.32M shares, 4.60%). Together, they hold 25.19% of Sarepta Therapeutics’s total shares outstanding.

Does Blackrock own Sarepta Therapeutics?

Yes, BlackRock owns 10.98% of Sarepta Therapeutics, totaling 10.32M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.63B$. In the last quarter, BlackRock increased its holdings by 4.36M shares, a 73.22% change.

Who is Sarepta Therapeutics’s biggest shareholder by percentage of total assets invested?

Casdin capital is Sarepta Therapeutics’s biggest shareholder by percentage of total assets invested, with 12.95% of its assets in 1.07M Sarepta Therapeutics shares, valued at 169.61M$.

Who is the top mutual fund holder of Sarepta Therapeutics shares?

iShares Core S&P Mid-Cap ETF is the top mutual fund holder of Sarepta Therapeutics shares, with 3.14% of its total shares outstanding invested in 3M Sarepta Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools